论文部分内容阅读
近十年来,免疫治疗作为肿瘤新疗法而引起较大注意,并广泛用于治疗白血病、黑色素瘤、肺癌。据报导卡介苗-细胞壁骨架(BCG-CWS)治疗人类肺癌是有效的,且副作用极少,但治疗胃癌的报道极少,故本文报道1978年1月到1978年12月140例胃癌病人应用BCG-CWS 治疗的研究结果。患者胃切除后,按双盲法随机分为三组:对照组、化疗组、化疗合并BCG-CWS 的免疫治疗组。对照组仅施行手术,化疗组在术后一周开始化疗,免疫治疗组在术后既用
In the past decade, immunotherapy has attracted considerable attention as a novel therapy for tumors and has been widely used in the treatment of leukemia, melanoma, and lung cancer. It has been reported that BCG-CWS is effective in the treatment of lung cancer in humans and has few side effects. However, there are few reports on the treatment of gastric cancer. Therefore, this article reports the use of BCG- in 140 patients with gastric cancer from January 1978 to December 1978. Results of the CWS treatment study. After gastrectomy, patients were randomly divided into three groups according to the double-blind method: control group, chemotherapy group, and chemotherapy combined with BCG-CWS immunotherapy group. The control group only performed surgery. The chemotherapy group started chemotherapy one week after surgery. The immunotherapy group was used after surgery.